©2022 Stanford Medicine
Cyberknife Radiosurgery and Quality of Life
Not Recruiting
Trial ID: NCT01163539
Purpose
The purpose of this study is to look at pain control and QOL improvement after treatment with
CK Radiosurgery for spinal metastases.
Official Title
Cyberknife Radiosurgery and Quality of Life
Stanford Investigator(s)
Steven D. Chang, MD
Robert C. and Jeannette Powell Neurosciences Professor and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS) and of Neurology
Eligibility
Inclusion Criteria:
- Patients with a spinal metastasis who will be treated with Cyberknife radiosurgery.
- There are no age or gender restrictions.
- There are no life expectancy restrictions.
- Karnofsky Performance Status greater than 40.
- Negative pregnancy test or clinically assessed as not pregnant.
- Ability to understand and the willingness to sign a written informed consent document.
Exclusion Criteria:
- Patients with benign tumors will not be included (neurofibromas, schwannomas, etc.)
- Other investigational medications or treatments will be noted, but will not preclude
inclusion.
- Pregnant or nursing patients will be not be included in the study due to radiation
exposure.
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
ccto-office@stanford.edu
650-498-7061